Delivery Order SPE2DB22D1017-SPE2DB25FG8ER
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60 count) with a ceiling value of $13,456.36. This is a firm fixed price delivery order with no set-aside designation, completed competitively, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 10, 2025. The award represents a single delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,398.61 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 500 mg tablets (60-count units) on June 12, 2025, with completion scheduled for June 13, 2025. The contract utilizes firm fixed price terms and is not designated as a set-aside award, indicating it was competitively awarded. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $21,098.76. This firm fixed-price delivery order, which has an ultimate completion date of June 3, 2025, carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded contract under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count packages) with a ceiling value of $184,749.89. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $1,463.13. This is a firm fixed-price, non-set-aside competitive award with an ultimate completion date of September 4, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a $46,593.78 delivery order to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count) on August 19, 2025, with completion scheduled for August 20, 2025. This competitively awarded, firm fixed price contract has no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $3,567.24. This competitively awarded, firm fixed-price contract was executed on July 22, 2025, with an ultimate completion date of July 23, 2025. The pharmaceutical product will be delivered from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) with a ceiling value of $3,276.40. This competitively awarded, non-set-aside delivery order operates under a firm fixed-price structure with an ultimate completion date of August 5, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Abiroterone Acetate 250 mg tablets (120-count supply) on September 15, 2025, with a ceiling value of $1,539.02. This competitive, firm fixed-price delivery order is scheduled for ultimate completion by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a $392,220 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 boxes of 250mg Abiraterone Acetate tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order has a period of performance from July 5, 2023 through July 6, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any particular contract vehicle. As the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8ERDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a ceiling value of $25,102.49. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a pediatric delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a billion-dollar pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The SPE2DX prime vendor contract enables the company to supply a comprehensive range of pharmaceuticals and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The current delivery order for Abiraterone Acetate, a hormone therapy medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 7/25/25 |